US Patent Issued to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE on Sept. 9 for "Microrna assay for detection and management of pancreatic cancer precursors" (Florida Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,479, issued on Sept. 9, was assigned to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (Tampa, Fla.).

"Microrna assay for detection and management of pancreatic cancer precursors" was invented by Mokenge P. Malafa (Tampa, Fla.), Jennifer Permuth (Tampa, Fla.) and Dung-Tsa Chen (Tampa, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The current invention pertains to miRNAs that are differentially expressed in samples of an individual having pancreatic cancer, or having a high risk of developing pancreatic cancer, as compared to the corresponding sample of an individual not having pancreatic cancer, or having low risk of developing panc...